Sign up to save your podcasts
Or
Share The New Hope for Alzheimer’s
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The New Hope for Alzheimer’s
Dr. Emer MacSweeney, CEO and Medical Director of Re:Cognition Health, and Tom Dent, Executive Chairman of Re:Cognition Health, discuss major advancements in treating cognitive disorders, including two new breakthough medications for Alzheimer’s. With the first of these revolutionary treatments now available on the market, Re:Cognition Health continues to lead, delivering these medications safely to individuals in both the USA and UK.
View all episodes
By Re:Cognition HealthDr. Emer MacSweeney, CEO and Medical Director of Re:Cognition Health, and Tom Dent, Executive Chairman of Re:Cognition Health, discuss major advancements in treating cognitive disorders, including two new breakthough medications for Alzheimer’s. With the first of these revolutionary treatments now available on the market, Re:Cognition Health continues to lead, delivering these medications safely to individuals in both the USA and UK.